Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1503

1.

Continuous Glucose Monitor Interference With Commonly Prescribed Medications.

Basu A, Slama MQ, Nicholson WT, Langman L, Peyser T, Carter R, Basu R.

J Diabetes Sci Technol. 2017 Mar 1:1932296817697329. doi: 10.1177/1932296817697329. [Epub ahead of print]

PMID:
28332406
2.

Randomized Controlled Trial of a MUFA or Fiber-rich diet on Hepatic fat in Pre-diabetes.

Errazuriz I, Dube S, Slama M, Visentin R, Nayar S, O'Connor H, Cobelli C, Das SK, Basu A, Kremers WK, Port J, Basu R.

J Clin Endocrinol Metab. 2017 Mar 6. doi: 10.1210/jc.2016-3722. [Epub ahead of print]

PMID:
28323952
3.

Molecular Mechanism Underlying the Action of the Influenza A Virus Fusion Inhibitor MBX2546.

Basu A, Komazin-Meredith G, McCarthy C, Antanasijevic A, Cardinale SC, Mishra RK, Barnard DL, Caffrey M, Rong L, Bowlin TL.

ACS Infect Dis. 2017 Mar 16. doi: 10.1021/acsinfecdis.6b00194. [Epub ahead of print]

PMID:
28301927
4.

Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2.

Basu A, Sridharan S.

PLoS One. 2017 Mar 16;12(3):e0173854. doi: 10.1371/journal.pone.0173854. eCollection 2017 Mar 16.

5.

Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype.

Basu A, Dalal A, Canonica GW, Forshag M, Yancey SW, Nagar S, Bell CF.

Expert Rev Pharmacoecon Outcomes Res. 2017 Mar 17:1-11. doi: 10.1080/14737167.2017.1298444. [Epub ahead of print]

PMID:
28277854
6.

DNA methylation profiling reveals the presence of population-specific signatures correlating with phenotypic characteristics.

Giri AK, Bharadwaj S, Banerjee P, Chakraborty S, Parekatt V, Rajashekar D, Tomar A, Ravindran A, Basu A, Tandon N, Bharadwaj D.

Mol Genet Genomics. 2017 Mar 7. doi: 10.1007/s00438-017-1298-0. [Epub ahead of print]

PMID:
28271161
7.

Investigation of gaze patterns in multi view laparoscopic surgery.

Kottayil NK, Bogdanova R, Cheng I, Bin Zheng, Basu A.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4031-4034. doi: 10.1109/EMBC.2016.7591611.

PMID:
28269168
8.

Low resolution tool tracking for microsurgical training in a simulated environment.

Furtado AC, Cheng I, Fung E, Bin Zheng, Basu A.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3843-3846. doi: 10.1109/EMBC.2016.7591566.

PMID:
28269124
9.

Determining team cognition from delay analysis using cross recurrence plot.

Hajari N, Cheng I, Bin Zheng, Basu A.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3482-3485. doi: 10.1109/EMBC.2016.7591478.

PMID:
28269049
10.

2SLS vs 2SRI: Appropriate Methods for Rare Outcomes and/or Rare Exposures.

Basu A, Coe NB.

Health Econ. 2017 Mar 5. doi: 10.1002/hec.3490. [Epub ahead of print]

PMID:
28260248
11.

Neurogenetic research: of mice and men … and misunderstanding.

Basu A.

Dev Med Child Neurol. 2017 Apr;59(4):342. doi: 10.1111/dmcn.13390. No abstract available.

12.

Metastatic Cutaneous Melanoma of the Gallbladder.

Patel D, Sohrawardy S, Sedhai YR, Basnyat S, Daxini A, Basu A, Mehta VR, Mohammed A, Lichtenstein S.

Case Rep Gastrointest Med. 2017;2017:8532379. doi: 10.1155/2017/8532379. Epub 2017 Jan 30.

13.

Issues for eHealth in Psychiatry: Results of an Expert Survey.

Nicholas J, Huckvale K, Larsen ME, Basu A, Batterham PJ, Shaw F, Sendi S.

J Med Internet Res. 2017 Feb 28;19(2):e55. doi: 10.2196/jmir.6957.

14.

Toward a Hedonic Value Framework in Health Care.

Basu A, Sullivan SD.

Value Health. 2017 Feb;20(2):261-265. doi: 10.1016/j.jval.2016.11.022.

PMID:
28237206
15.

Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.

Ríos-Colón L, Cajigas-Du Ross CK, Basu A, Elix C, Alicea-Polanco I, Sanchez TW, Radhakrishnan V, Chen CS, Casiano CA.

Oncotarget. 2017 Feb 14. doi: 10.18632/oncotarget.15323. [Epub ahead of print]

16.

Nonequilibrium steady states in a closed inhomogeneous asymmetric exclusion process with generic particle nonconservation.

Daga B, Mondal S, Chandra AK, Banerjee T, Basu A.

Phys Rev E. 2017 Jan;95(1-1):012113. doi: 10.1103/PhysRevE.95.012113. Epub 2017 Jan 9.

PMID:
28208456
17.

The host microRNA miR-301a blocks the IRF1-mediated neuronal innate immune response to Japanese encephalitis virus infection.

Hazra B, Kumawat KL, Basu A.

Sci Signal. 2017 Feb 14;10(466):eaaf5185. doi: 10.1126/scisignal.aaf5185.

PMID:
28196914
18.

Are evidence standards different for genomic- vs. clinical-based precision medicine? - A quantitative analysis of individualized warfarin therapy.

Dhanda DS, Guzauskas GF, Carlson JJ, Basu A, Veenstra DL.

Clin Pharmacol Ther. 2017 Feb 10. doi: 10.1002/cpt.663. [Epub ahead of print]

PMID:
28187492
19.

Myonecrosis in Sickle Cell Anemia: Case Study.

Turaga LP, Boddu P, Kipferl S, Basu A, Yorath M.

Am J Case Rep. 2017 Jan 30;18:100-103.

20.

Japanese encephalitis virus induces human neural stem/progenitor cell death by elevating GRP78, PHB and hnRNPC through ER stress.

Mukherjee S, Singh N, Sengupta N, Fatima M, Seth P, Mahadevan A, Shankar SK, Bhattacharyya A, Basu A.

Cell Death Dis. 2017 Jan 19;8(1):e2556. doi: 10.1038/cddis.2016.394.

PMID:
28102850

Supplemental Content

Loading ...
Support Center